Susan Moran Net Worth

What's Susan Moran's mailing address?

Susan's mailing address filed with the SEC is C/O BIOATLA, INC. 11085 TORREYANA ROAD, , SAN DIEGO, CA, 92121.

Insiders trading at BioAtla

Over the last 4 years, insiders at BioAtla have traded over 51,913,006$ worth of BioAtla stock and bought 2,491,625 units worth 40,365,176$ . The most active insiders traders include Guy Levy、Asset Management, Lp Chen B...、Jay M Phd Short. On average, BioAtla executives and independent directors trade stock every 25 days with the average trade being worth of 157,753$. The most recent stock trade was executed by Sylvia Mcbrinn on 26 December 2023, trading 4,000 units of BCAB stock currently worth 9,320$.

What does BioAtla do?

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

BioAtla executives and stock owners

BioAtla executives and other stock owners filed with the SEC include:

• Dr. Jay M. Short,
  Co-Founder, CEO & Chairman
• Scott Andrew Smith,
  Pres & Director
• Dr. Eric L. Sievers M.D.,
  Chief Medical Officer
• Monica Sullivan,
  Sr. VP of Intellectual Property & Contracts
• Christian Vasquez,
  VP of Fin., Corp. Controller & Sec.
• Sheri Lydick,
  Sr. VP of Commercial Strategy
• Dr. Eric L. Sievers,
  Chief Medical Officer
• Dr. Cathy Chang Ph.D.,
  Sr. VP of R&D
• Susie Melody,
  VP of HR
• Lisa M. Pelton,
  Accounting Mang.
• Philippe Martin,
  Chief Clinical Devel. & Operations
• Richard A. Waldron,
  Chief Financial Officer
• Lawrence Steinman,
  
• Asset Management, Lp Chen B...,
  
• Inc Pfizer Ventures (Us) Ll...,
  
• Christian Vasquez,
  See Remarks
• Jay M Phd Short,
  Chief Executive Officer
• Richard A Waldron,
  Chief Financial Officer
• Carolyn Anderson Short,
  See Remarks
• Eric Sievers,
  Chief Medical Officer
• Guy Levy,
  
• Mary Ann Gray,
  
• Susan Moran,
  
• Parent Llc Himalaya,
  10% owner
• Sylvia Mcbrinn,
  
• Eddie Williams,